spacer
home > pmps > winter 2010 > identity, integrity, authenticity
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Identity, Integrity, Authenticity

Behind the three words of the title, there are many different meanings, and a lot of confusion, which this article will seek to clarify. This is one of the darkest areas in the industrial world, and especially the pharmaceutical industry. All project managers in this sector are currently focused on track and trace projects and ways of softly implementing new coding requirements on production lines with a minimum of immediate investment, but with enough attention to prepare the coming years and anticipated evolutions in regulation, such as aggregation.

So, identity, integrity, authenticity, track and trace, aggregation – it is worth taking some time to clarify these terms and what is it hidden behind them.

The European Federation of Pharmaceutical Industries and Associations (EFPIA) is pushing to put a unique code in place for secondary packaging, to bring an identity to each pack, even from the same batch number. By using this unique number, everybody will be able to identify one pack from another. Pack 1 and pack 2, from the same batch, produced the same day on the same production line and with the same expiry date, are different, because they have two different identities, two unique codes. This unique code defines the product itself, its production date, from which country, from which production line, its expiry date, at what point in the batch it was produced (beginning, middle or end) just as your passport defines who you are, where you are from, and so on. To conclude, a unique code defines the pack’s identity.

As a producer, you have to follow your production, not only on your production lines and plants, but also through the complete supply chain from distribution centres to retailers and to customers or patients. You have already traced your products by giving them an identity. If you’re able to check these identities along the supply chain, you’ll be able to track them. It is rather like several Customs controls at an airport. The different Customs officers will successively check your identity or passport, and are able to trace your complete trip from one country to another.

The EFPIA also recommends multiple controls to prevent counterfeiters or smugglers from introducing fake products on a legal product flow or to divert real products from their original destination to another one. To conclude this part, by defining the identity of your product and by checking it as much as possible from plant to customer, you track and trace your production.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Thierry Protas has been managing codification, serialisation, track and trace and authentication projects for more than 10 years across different sectors, but more specifically in the pharmaceutical industry. He has competencies in different fields, including printer technologies, automation devices and PLC and software project management. He joined Arjowiggins Security to use these competencies to manage security projects with customers in the pharmaceutical and agrochemical industries. Email: thierry.protas@arjowiggins.com
spacer
Thierry Protas
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

Keeping Abreast of the Competitive Environment in Clinical Development

Thomson Reuters

Strategic management of a therapy area requires hard decisions to be made about which programs to invest in and which to let go. Understanding the rapidly changing competitive environment for your drug candidates is a key input into these decisions. It is easy to lose track of the broader picture when a clinical program is in progress and get blindsided by external events.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement